All News

Women have a 20% higher risk than men of dying or facing heart failure, and they typically experience NSTEMI heart attacks.

Decreases in prescription opioid volume over the past 9 years have been driven by changes in clinical use, regulatory, and reimbursement policies, and in progressively more restrictive legislation enacted since 2012.

The researchers familiarized mice with objects and gave them doses of melatonin and the 2 melabolites 1 hour later, followed by a test on their memory the next day.

FDA approves margetuximab-cmkb (Margenza) in combination with chemotherapy for the treatment of adult patients with metastatic HER2-positive breast cancer who have previously received 2 or more anti-HER2 regimens.

Baclofen Tablets are used to treat muscle pain, spasms, and stiffness in people with multiple sclerosis or spinal cord injury or disease.

Results of Ellume’s rapid at-home COVID-19 test are sent to a smartphone in 15 minutes or less.

There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.

Tips and tricks to make mask-wearing less problematic during the COVID-19 pandemic.

Functional medicine has grown in popularity throughout the years because of how it helped many patients live a better quality of life.

Beta-carotene is the bioactive compound that gives carrots their orange color, with studies in humans and mice showing the conversion of beta-carotene to vitamin A as reducing bad cholesterol in the blood.

The FDA has granted a fast track designation to devimistat (CPI-613) for the treatment of patients with acute myeloid leukemia.

Study aims to increase patient access to clinical care delivered in community pharmacies by leveraging the expanded roles of pharmacy technicians.

Tirbanibulin is expected to be launched in the United States during the first quarter of 2021.

Among a subset of participants in the COVID-19 vaccine clinical trials, 0.63% of individuals in the vaccinated group had hypersensitivity-related adverse events that may represent allergic reactions.

Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.

Financial toxicity can lead to worse long-term outcomes and psychological distress among patients with breast cancer.

The FDA is expected to review the safety and efficacy data package from Moderna's COVID-19 vaccine candidate on December 17, which could lead to an EUA being issued this week.

As administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.

Learn how you and your staff can help patients differentiate between common cough/cold symptoms and COVID-19 while also offering additional educational resources.

Supreme Court ruling clears the way for states to pass laws that protect pharmacies from predatory reimbursement practices by PBMs.

Study shows the mortality rate among breast cancer survivors is lower among those who received fertility preservation.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

The papers in the special issue highlight the research team’s focus on understanding the experiences of caregivers of persons with TBI and illustrate the team’s ability to efficiently capture those experiences through a tool known as TBI-CareQOL Measurement System.

Individuals who reported zero or fewer live births and those who reported many live births had markers of quicker aging than those who reported 3 or 4 births.

The cost of oncology treatment is high and rising in the United States.

Distribution of the first 2.9 million doses of the COVID--19 vaccine jointly developed by Pfizer and BioNTech are expected to begin within hours of the FDA’s decision.

A member of the FDA’s expert advisory committee who voted in favor of Pfizer and BioNTech’s COVID-19 vaccine said that distribution of the first vaccines to high priority populations in the United States could begin as early as Monday.

Genetic predisposition is only part of the pre-eclampsia risk.